Viewing Study NCT04631016


Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-03-20 @ 8:02 AM
Study NCT ID: NCT04631016
Status: COMPLETED
Last Update Posted: 2025-02-27
First Post: 2020-10-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease (COPD) View
None Chronic Bronchitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEDI3506 View
None IL-33 View
None COPD View
None Chronic Bronchitis View
None Lung function View
None Inflammation View